Edwards Lifesciences Corp (EW)
85.50
+0.41
(+0.48%)
USD |
NYSE |
May 07, 10:05
Edwards Lifesciences Research and Development Expense (TTM): 1.096B for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.096B |
| December 31, 2023 | 1.072B |
| September 30, 2023 | 1.034B |
| June 30, 2023 | 997.30M |
| March 31, 2023 | 977.80M |
| December 31, 2022 | 945.20M |
| September 30, 2022 | 945.80M |
| June 30, 2022 | 950.20M |
| March 31, 2022 | 924.70M |
| December 31, 2021 | 903.10M |
| September 30, 2021 | 866.00M |
| June 30, 2021 | 823.50M |
| March 31, 2021 | 780.30M |
| December 31, 2020 | 760.70M |
| September 30, 2020 | 758.90M |
| June 30, 2020 | 758.90M |
| March 31, 2020 | 768.70M |
| December 31, 2019 | 752.70M |
| September 30, 2019 | 721.90M |
| June 30, 2019 | 688.20M |
| March 31, 2019 | 650.40M |
| December 31, 2018 | 622.20M |
| September 30, 2018 | 605.70M |
| June 30, 2018 | 586.80M |
| March 31, 2018 | 567.10M |
| Date | Value |
|---|---|
| December 31, 2017 | 552.60M |
| September 30, 2017 | 520.90M |
| June 30, 2017 | 491.00M |
| March 31, 2017 | 503.60M |
| December 31, 2016 | 476.70M |
| September 30, 2016 | 459.80M |
| June 30, 2016 | 447.80M |
| March 31, 2016 | 398.30M |
| December 31, 2015 | 382.90M |
| September 30, 2015 | 379.10M |
| June 30, 2015 | 365.70M |
| March 31, 2015 | 357.30M |
| December 31, 2014 | 356.70M |
| September 30, 2014 | 341.10M |
| June 30, 2014 | 337.60M |
| March 31, 2014 | 329.00M |
| December 31, 2013 | 323.00M |
| September 30, 2013 | 319.30M |
| June 30, 2013 | 309.00M |
| March 31, 2013 | 302.50M |
| December 31, 2012 | 291.30M |
| September 30, 2012 | 277.10M |
| June 30, 2012 | 265.00M |
| March 31, 2012 | 255.90M |
| December 31, 2011 | 246.30M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
688.20M
Minimum
Jun 2019
1.096B
Maximum
Mar 2024
876.28M
Average
884.55M
Median
Research and Development Expense (TTM) Benchmarks
| Stryker Corp | 1.417B |
| Align Technology Inc | 351.24M |
| Abbott Laboratories | 2.771B |
| Boston Scientific Corp | 1.444B |
| Steris PLC | 104.85M |